AVTX

Avalo Therapeutics, Inc.

Next Earnings

Nov 06, 2026

Net Activity (1Y)

-$1.7M

Net Activity (90D)

-$1.7M

Insider Activity Graph

(14 shown · 47 raw)

Green/Red bubbles = daily net insider value (size = magnitude), Blue line = daily close price, E = earnings-related SEC filing

Insider trades for this company
Insider	Title	Type	Date ↓	Shares	Value
Christopher Ryan Sullivan	Chief Financial Officer	Sale	2026-08-18	31,031	$622K
Christopher Ryan Sullivan	Chief Financial Officer	Sale	2026-08-17	41,694	$828K
Mittie Doyle	Chief Medical Officer	Sale	2026-08-17	1,000	$20K
Jennifer Riley	Chief Strategy Officer	Sale	2026-08-11	2,655	$52K
Mittie Doyle	Chief Medical Officer	Sale	2026-08-10	679	$14K
Mittie Doyle	Chief Medical Officer	Sale	2026-07-27	1,000	$20K
Mittie Doyle	Chief Medical Officer	Sale	2026-06-30	4,654	$93K
Mittie Doyle	Chief Medical Officer	Sale	2026-06-23	1,450	$26K
Jennifer Riley	Chief Strategy Officer	Tax Withhold	2026-06-10	588	$8K
Paul Varki	Chief Legal Officer	Tax Withhold	2026-06-10	1,081	$14K
Christopher Ryan Sullivan	Chief Financial Officer	Tax Withhold	2026-06-10	138	$2K
Mittie Doyle	Chief Medical Officer	Tax Withhold	2026-06-10	1,084	$14K
Mittie Doyle	Chief Medical Officer	Sale	2026-05-28	679	$11K